Genomictree Balance Sheet Health
Financial Health criteria checks 6/6
Genomictree has a total shareholder equity of ₩125.0B and total debt of ₩1.7B, which brings its debt-to-equity ratio to 1.4%. Its total assets and total liabilities are ₩132.8B and ₩7.8B respectively.
Key information
1.4%
Debt to equity ratio
₩1.69b
Debt
Interest coverage ratio | n/a |
Cash | ₩93.15b |
Equity | ₩125.03b |
Total liabilities | ₩7.81b |
Total assets | ₩132.84b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A228760's short term assets (₩95.4B) exceed its short term liabilities (₩5.3B).
Long Term Liabilities: A228760's short term assets (₩95.4B) exceed its long term liabilities (₩2.5B).
Debt to Equity History and Analysis
Debt Level: A228760 has more cash than its total debt.
Reducing Debt: A228760's debt to equity ratio has reduced from 8.1% to 1.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A228760 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A228760 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 7.1% each year